To assess this, cells were grown until confluent and siRNAs against DRAM1 in T2DM cells and against VAMP8 and TP53INP1 in cells from healthy donors were used to knock down their respective target mRNAs. This evidence concerns the gene DRAM1 and type 2 diabetes mellitus.